Home - Small population statistics

About Us

We provide more than statistical analysis — we become your strategic partner.

At NooScend, we bridge advanced clinical Trials Programming. AI-driven QC and digital twin simulations to deliver results that are not only accurate but regulatory-ready. Every dataset, table, and figure we produce is built on compliance, transparency, and innovation.

Our Services

Biostatistics & Programming

Clinical Programming

Fully validated, CDISC-compliant clinical programming services for SDTM and ADaM datasets, TLF shells, statistical outputs, and submission-ready clinical trial reporting.

Small Population Trial Statistics

We How adaptive designs, Bayesian methods, natural history data, and real-world evidence help rare disease trials produce meaningful results with limited patient numbers.

Digital Twins in Clinical Trials

Learn how digital twins in clinical trials use patient cohort simulation, dosage optimization, and outcome prediction to improve trial design and reduce study failure.

Adaptive Designs For Rare Disease

Our flexible trial designs help rare disease studies generate stronger evidence with small patient populations.

AI-Driven QC Automation

AI-driven QC automation for clinical trials. QC Hub validates datasets, cross-checks SAP, CRF, and define.xml, and generates audit-ready QC reports.

Natural History Data Analysis

help to understand disease progression, select endpoints, support external controls, and generate stronger evidence in small populations.

Clinical Trial Design

Exceeding Expectations With Every Result

We transform clinical data into validated insights with precision, speed, and compliance. Every dataset and every model we deliver is built to exceed expectations.

Dermatology Trials

pidermolysis bullosa (EB), pemphigus and pemphigoid, hidradenitis suppurativa (HS), alopecia areata (AA), vitiligo, ichthyosis, cutaneous lupus erythematosus (CLE), Netherton syndrome, pachyonychia congenita, morphea, and other rare genodermatoses.

Orphan Oncology Trials

soft tissue sarcomas, bone sarcomas, cholangiocarcinoma and biliary malignancies, mesothelioma, pediatric central nervous system (CNS) tumors, neuroendocrine tumors (NET), thymic malignancies, adrenocortical carcinoma (ACC), Merkel cell carcinoma (MCC), and desmoid tumors.

Hematology Trials

sickle cell disease (SCD), hemophilia A and B, beta-thalassemia, paroxysmal nocturnal hemoglobinuria (PNH), aplastic anemia (AA), thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS), von Willebrand disease (VWD), cold agglutinin disease (CAD), and pyruvate kinase deficiency (PKD).

Neurology Trials

spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), Dravet syndrome, Rett syndrome, Friedreich ataxia, and leukodystrophies.

Metabolic Trials

lysosomal storage disorders (LSDs) and select inborn errors of metabolism (IEM): Fabry disease, Gaucher disease, Pompe disease, mucopolysaccharidoses (MPS), phenylketonuria (PKU), Niemann-Pick disease, and cystinosis.